ctrl K

Price Alert

Protagonist Therapeutics ... (PTGX)

NASDAQ: PTGX · Real-Time Price · USD

56.34

0.13 (0.23%)

At close: Aug 19, 2025, 1:50 PM

Protagonist Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	97.25M	186.73M	125.74M	123.67M
Short-Term Investments	321.66M	154.89M	111.61M	203.24M
Long-Term Investments	140.25M	n/a	225K	225K
Other Long-Term Assets	225K	225K	5.72M	n/a
Receivables	168.49M	10.33M	52K	1.57M
Inventory	n/a	n/a	-94K	8.5M
Other Current Assets	n/a	n/a	n/a	3.77M
Total Current Assets	591.64M	355.58M	237.35M	340.74M
Property-Plant & Equipment	12.61M	2.15M	4.63M	6.73M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	153.08M	2.37M	10.57M	6.96M
Total Assets	744.73M	357.95M	247.93M	347.69M
Account Payables	1.61M	772K	3.64M	1.6M
Deferred Revenue	18.89M	n/a	69K	1.6M
Short-Term Debt	n/a	n/a	2.52M	2.2M
Other Current Liabilities	23.69M	6.79M	17.54M	28.88M
Total Current Liabilities	47.4M	21.27M	31.18M	44.02M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	11.68M	-221K	n/a	n/a
Total Long-Term Liabilities	22.03M	n/a	784.68M	3.66M
Total Liabilities	69.43M	21.27M	784.68M	47.67M
Total Debt	10.87M	1.14M	3.66M	5.86M
Common Stock	1K	1K	n/a	n/a
Retained Earnings	-340.52M	-615.71M	-536.75M	-409.36M
Comprehensive Income	-82K	-105K	-359K	-299K
Shareholders Equity	675.29M	336.68M	-536.75M	-409.36M
Total Investments	461.92M	154.89M	111.61M	203.24M